OTC : LSBCF
$0 (0.0%)
| Source | Headline |
|---|---|
|
LSBCF Investors Have Opportunity to Join LakeShore Biopharma Co., Ltd Fraud Investigation with the Schall Law Firm
LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or “the Company”) (OTC: LSBCF) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. globenewswire.com - 2026-05-08 17:57:00 |